Chronic low dose islet amyloid polypeptide infusion reduces food intake, but does not influence glucose metabolism, in unrestrained conscious rats: Studies using a novel aortic catheterization technique

Endocrinology

Volumn 138, Issue 10, 1997, Pages 4081-4085

  Arnelo, Urban ^a,c   Permert, Johan ^c   Larsson, Jörgen ^c   Reidelberger, Roger D ^a,b   Arnelo, Catarina ^c   Adrian, Thomas E ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN;

ANIMAL EXPERIMENT; ARTERY CATHETERIZATION; ARTICLE; CONTROLLED STUDY; FOOD INTAKE; GLUCOSE METABOLISM; HORMONE ACTION; HORMONE DETERMINATION; HYPERINSULINEMIA; INDWELLING CATHETER; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

EID: 0030988868     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.10.5264     Document Type: Article

References (37)

1. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH 1987 Amyloid fibrils in human insulinoma islets of Langerhans of the diabetic cat are derived from the neuropeptide like protein also present in normal islet cells. Proc Natl Acad Sci USA 84:3881-3885
2. Westermark P, Wernstedt C, Wilander E, Sletten K 1986 A novel peptide in the calcitonin gene related family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140:827-831
3. Cooper GJS, Willis AC, Clark A, Turner RC, Sim SB, Reid KBM 1987 Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84:8628-8632
4. Lukinius A, Wilander E, Westermark GT, Engström U, Westermark P 1989 Co-localization of islet amyloid polypeptide and insulin and the B cell secretory granules of the human pancreatic islets. Diabetologia 32:240-244
5. Kahn SE, D'Alessio DA, Schwartz W, Fujimoto WY, Ensinck JW, Taborsky GJ, Porte D 1990 Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells. Diabetes 39:634-638
6. Mitsukawa T, Takemura J, Asai J, Nakazato M, Kangawa K, Matsuo H, Matsukura S 1990 Islet amyloid polypeptide response to glucose, insulin and somatostatin analogue administration. Diabetes 39:639-642
7. Nakazato M, Miyazato M, Asai J, Mitzukawa T, Kangawa K, Matsuo H, Matsukura S 1990 Islet amyloid polypeptide, a novel pancreatic peptide, is a circulating hormone secreted under glucose stimulation. Biochem Biophys Res Commun 169:713-718
8. van Jaarsveld BC, Hackeng WHL, Nieuwenhuis MG, Erkelens DW, Geerdink RA, Lips CJM 1990 Islet-amyloid polypeptide in human plasma. Lancet 335:60
9. Butler PC, Chou J, Carter WB, Wang YN, Bu BH, Chang D, Chang JK, Rizza R 1990 Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39:752-756
10. Permert J, Larsson J, Westermark GT, Herrington MK, Christmansson L, Pour PM, Westermark P, Adrian TE 1994 Islet amyloid polypeptide in patients with pancreatic cancer patients and diabetes. N Engl J Med 330:313-318
11. Ingelfinger FJ 1946 The diagnosis of cancer of the pancreas. N Engl J Med 235:653-661
12. Schwartz SS, Ziedler A, Moossa AR, Kuku SF, Rubenstein AH 1978 A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma. Am J Dig Dis 23:1107-1114
13. Permert J, Ihse I, Jorfeldt L, von Schenk H, Arnqvist HJ, Larsson J 1993 Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 159:101-107
14. Arnelo U, Permert J, Adrian TE, Larsson J, Westermark P, Reidelberger RD Chronic infusion of islet amyloid polypeptide causes anorexia in rats. Am J Physiol 271:R1654-R1659
15. Weeks JR 1972 Long-term intravenous infusion. In: Myers RD (ed) Methods in Psychobiology. Academic Press, London, vol 2:155-168
16. Waynforth HB, Flecknell PA 1992 Catheterisation of the jugular vein. In: Waynforth HB, Flecknell PA (eds) Experimental and Surgical Technique in the Rat. Academic Press, London, pp 215-222
17. Arnelo U, Blevins JE, Larsson J, Permert J, Westermark P, Reidelberger RD, Adrian TE 1996 Effects of acute and chronic infusion of islet amyloid polypeptide on food intake in rats. Scand J Gastroenterol 31:83-89
18. DeFronzo R, Tobin JD, Andres R 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
19. Ziel FH, Venkatesan N, Davidson MB 1988 Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats. Diabetes 37:885-890
20. Chance WT, Balasubramaniam A, Zhang FS, Wimalawansa SJ, Fischer JE 1991 Anorexia following the intrahypothalamic administration of amylin. Brain Res 539:352-354
21. Bouali SM, Wimalawansa SJ, Jolicoeur FB 1995 In vivo central actions of rat amylin. Regul Pept 56:167-174
22. Lutz TA, Del Prete E, Scharrer E 1995 Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin. Peptides 16:457-462
23. Young AA, Gedulin B, Vine W, Percy A, Rink TJ 1995 Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Diabetologia 38:642-648
24. Molina JM, Cooper GJS, Leighton B, Olefsky JM 1990 Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide. Diabetes 39:260-265
25. Sowa R, Sanke T, Hirayama J, Tabata H, Furuta H, Nishimura S, Nanjo K 1990 Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs. Diabetologia 33:118-120
26. Bretherton-Watt D, Gilbey SG, Ghatei MA, Beacham J, Macrae AD, Bloom SR 1992 Very high concentrations of islet amyloid polypeptide are necessary to alter the insulin response to intravenous glucose in man. J Clin Endocrinol Metab 74:1032-1035
27. Fürnsinn C, Nowotny P, Roden M, Rohac M, Pieber T, Parzer S, Waldhäusl W 1993 Insulin resistance caused by amylin in conscious rats is independent of induced hypocalcemia and fades during long-term exposure. Acta Endocrinol (Copenh) 129:360-365
28. Frontoni S, Choi SB, Banduch D, Rosetti L 1991 In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glucogen synthesis in skeletal muscle. Diabetes 40:568-573
29. Johnson KH, O'Brien TD, Jordan K, Betsholtz C, Westermark P 1990 The putative hormone islet amyloid polypeptide (IAPP) induces impaired glucose tolerance in cats. Biochem Biophys Res Commun 167:507-513
30. Panagiotidis G, Salehi AA, Westermark P, Lundquist I 1992 Homologous islet amyloid polypeptide: effects on plasma levels of glucagon, insulin and glucose in the mouse. Diabetes Res Clin Pract 18:167-171
31. Leighton B, Cooper GJS 1988 Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335:632-635
32. Mitsukawa T, Takemura J, Nakazato M, Asai J, Kangawa K, Matsuo H, Matsukura S 1992 Effects of aging on plasma islet amyloid polypeptide basal level and response to oral glucose load. Diabetes Res Clin Pract 15:131-134
33. Wang M-W, Carlo P, Fineman M, Rink TJ, Young AA 1992 Induction of acute hyperglycemia, hyperlactemia and hypocalcemia in fed and fasted BALB/c mice by intravenous amylin injection. Endocr Res 18:321-332
34. Wang M-W, Carlo P, Rink TJ, Young AA 1991 Amylin is more potent and more effective than glucagon in raising plasma glucose concentration in fasted, anesthetized rats. Biochem Biophys Res Commun 181:1288-1293
35. Young AA, Cooper GJS, Carlo P, Rink TJ, Wang M-W 1993 Response to intravenous injection of amylin and glucagon in fasted, fed, and hypoglycemic rats. Am J Physiol 264:E943-E950
36. Young AA, Rink TJ, Wang M-W 1993 Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRPα) in the fasted, anesthetized rat. Life Sci 52:1717-1726
37. Young DA, Deems RO, Deacon RW, McIntosh RH, Foley JE 1990 Effects of amylin on glucose metabolism and glycogenolysis in vivo and in vitro. Am J Physiol 259:E457-E461